Amgen Inc., AMGN is in the exchange NASDAQ and its industry is Biotechnology in the sector of Healthcare. Based in USA, Amgen Inc., AMGN has a market cap of 130245.92. Since its IPO date on the 9/7/1984, Amgen Inc., AMGN performance year to date is 8.29%. Today Amgen Inc., AMGN has gained -0.34%, with a current price of 172.84.
Ownership of the company is 0.20% for insider ownership while institutional ownership is 81.70%. The management of the company have seen the company have a payout ratio of *TBA. Return of assets are at *TBA, with return on investment at 12.50%.
In terms of debt levels and profit levels, Amgen Inc., AMGN is seeing a long-term debt/equity of *TBA. While Total debt/equity is *TBA. With a profit margin of *TBA, this is combined with a gross margin of 81.00%, and operating margin of 41.30%. Amgen Inc. ability to meet debt levels, with a current ratio of 4, while the quick ratio is 3.7.
For the last year Amgen Inc., AMGN has seen a EPS growth of 35.20%. A performance for the year of 1.54%. The 52-week high is -2.07%, and the 52-week low is 35.35%. The average volume for Amgen Inc., AMGN is 910551.
With a target price of 189.94, can Amgen Inc., AMGN reach this target? Looking at the value indicators of Amgen Inc., AMGN. Amgen Inc. has a P/E of 18.35 and a forward P/E of 13.99. Perhaps the more useful indicator than P/E, is PEG which has a value of 2.16. Amgen Inc. also has a P/S and a P/B of 5.88 and 4.31 respectively. For P/cash, Amgen Inc. has a value of *TBA, while it is *TBA for P/free cash flow.
At the current price of 172.84, Amgen Inc. has a dividend yield of 2.31%. We see a return on equity of *TBA.
Looking more long-term Amgen Inc., is projected to get an EPS growth for the next five years of 8.50%. In the short-term an EPS growth of 9.30% in the next year is forecasted. This is after a EPS growth of 35.20% for this year and for the last five years a 13.60% growth has been seen.